Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Vasculitis
•
GCA
What imaging do you prefer for screening of large vessel involvement in GCA and do you routinely get that in all newly diagnosed cases?
Related Questions
How would you approach management of nodular scleritis in the setting of suspected GCA?
Would you consider tocilizumab for treatment of GCA in patients with underlying CLL (not requiring therapy)?
How soon after starting treatment would you repeat imaging in patients with Takayasu to monitor response and ensure you have the correct diagnosis?
Would you give IVIG for Rituximab induced immunodeficiency in patients with reduced kidney function from renal GPA?
Do you consider immunosuppression in a patient with cocaine-induced midline lesions who is ANCA positive, but has no other evidence of vasculitis?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
How do you interpret a negative ANCA and a low positive PR3?
How would you approach management of a patient with classic GCA symptoms, elevated ESR and improvement with steroids, but negative temporal artery biopsy and CTA imaging without evidence of vasculitis?
Do you utilize temporal artery ultrasound in your practice?
How soon after starting treatment for Takayasu arteritis do you decide on the need for any vascular interventions to manage chronic damage?
